Title | Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening. |
Publication Type | Journal Article |
Year of Publication | 2016 |
Authors | Kumar B, Khaleghzadegan S, Mears B, Hatano K, Kudrolli TA, Chowdhury WH, Yeater DB, Ewing CM, Luo J, Isaacs WB, Marchionni L, Lupold SE |
Journal | Oncotarget |
Volume | 7 |
Issue | 45 |
Pagination | 72593-72607 |
Date Published | 2016 11 08 |
ISSN | 1949-2553 |
Keywords | Cell Line, Tumor, Cell Proliferation, Gene Library, High-Throughput Nucleotide Sequencing, Humans, Male, MicroRNAs, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen, Signal Transduction, Transfection |
Abstract | The Androgen Receptor (AR) plays a key role in prostate biology and in the progression of prostate cancer (PCa) to castration resistance. The role of microRNAs (miRNAs) in aberrant AR signaling have not been fully characterized. Here we screened a library of 810 miRNA mimics to identify miRNAs that alter AR activity in complementary functional assays including protein lysate microarray (LMA) quantification of AR and PSA protein levels, AR transcriptional reporter activity, and AR-positive PCa cell viability. Candidate AR-regulating miRNAs were verified through AR transcriptional reporter and cell viability assays. MiRNA binding sites were found within the AR 3'-untranslated region (UTR) and within the AR and AR-V7 coding regions. MiRNA activity was characterized by western blotting, 3'-UTR reporter assay, and AR-GFP and AR-V7-GFP reporter assays. Results uncovered miR-30 family members as direct AR inhibitors. Inhibition of endogenous miR-30b-3p and miR-30d-5p enhanced AR expression and androgen-independent cell growth. Droplet digital RT-PCR quantification of miR-30c-5p and miR-30d-5p revealed significantly reduced levels in metastatic castration resistant PCa (CRPC), when compared to healthy prostate tissues. MiR-30d-5p levels were inversely correlated with AR activity, as measured by PSA mRNA, in metastatic CRPC. Collectively, these studies provide a comprehensive evaluation of AR-regulating miRNAs in PCa. |
DOI | 10.18632/oncotarget.12241 |
Alternate Journal | Oncotarget |
PubMed ID | 27683042 |
PubMed Central ID | PMC5341930 |
Grant List | P30 CA006973 / CA / NCI NIH HHS / United States R01 CA143299 / CA / NCI NIH HHS / United States UL1 TR001079 / TR / NCATS NIH HHS / United States |
Related Faculty:
Luigi Marchionni, M.D., Ph.D.